HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial-Reference-Cited by-同舟云学术

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

Published:2010-09-22 Issue:2 Volume:124 Page:403-412
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Fehm Tanja,Müller Volkmar,Aktas Bahriye,Janni Wolfgang,Schneeweiss Andreas,Stickeler Elmar,Lattrich Claus,Löhberg Christian R.,Solomayer Erich,Rack Brigitte,Riethdorf Sabine,Klein Christoph,Schindlbeck Christian,Brocker Kerstin,Kasimir-Bauer Sabine,Wallwiener Diethelm,Pantel Klaus

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-010-1163-x.pdf

Reference38 articles.

1. Coussens L, Yang-Feng TL, Lioa YC, Chen E, Gray A, Mc Grath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levison A, Ulrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132–1139

2. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg AR (1984) The neu oncogene: an erbB-related gene encoding a 185,000-Mr tumour antigen. Nature 312:513–516

3. Slamon DJ, Goldolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast cancer and ovarian cancer. Science 244:707–712

4. Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ (2003) Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst 95:142–153

5. Moliterni A, Ménard S, Valagussa P, Biganzoli E, Boracchi P, Balsari A, Casalini P, Tomasic G, Marubini E, Pilotti S, Bonadonna G (2003) HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer. J Clin Oncol 21:458–462

Cited by 309 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors;Critical Reviews in Oncology/Hematology;2024-11

2. The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancer;BMC Cancer;2024-08-29

3. Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine;Current Opinion in Oncology;2024-07-16

4. Reporting on invasive lobular breast cancer in clinical trials: a systematic review;npj Breast Cancer;2024-03-20

5. Training an automated circulating tumor cell classifier when the true classification is uncertain;PNAS Nexus;2024-02-01